@ARTICLE{
author={Belancic Andrej,Gkrinia Elvira Meni Maria,Sel Eda Kubra,Roncato Rossana,Jankovic Slobodan M,Vitezic Dinko},
year={2026},
title={A systematic literature review of economic evaluations of setmelanotide},
journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
volume={82},
number={5},
pages={-},
document_type={Review},
} 

@ARTICLE{
author={Belancic Andrej,Eustaquio Patrick,Gkrinia Elvira Meni Maria,Stevic Ivana,Javor Eugen,Lam Yun Wah,Jankovic Slobodan M,Vitezic Dinko},
year={2026},
title={The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovations},
journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
volume={},
number={},
pages={-},
document_type={Review; Early Access},
} 

@ARTICLE{
author={Belancic Andrej,Litonius Kaisa,Kulla Noora,Likic Robert,Jankovic Slobodan M,Vitezic Dinko,Backman Janne T},
year={2025},
title={Early-career pre-congress meetings: investing in talent, transforming the future of clinical pharmacology},
journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY},
volume={82},
number={1},
pages={-},
document_type={Letter},
} 

@ARTICLE{
author={Belancic Andrej,Stevic Ivana,Gkrinia Elvira Meni Maria,Vitezic Dinko,Jankovic Slobodan M},
year={2025},
title={Cost-utility analysis of nusinersen-risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model},
journal={BRITISH JOURNAL OF CLINICAL PHARMACOLOGY},
volume={},
number={},
pages={-},
document_type={Article; Early Access},
} 

@ARTICLE{
author={Sel Eda Kubra,Gkrinia Elvira Meni Maria,Roncato Rossana,Vitezic Dinko,Jankovic Slobodan M,Belancic Andrej},
year={2025},
title={Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence},
journal={JOURNAL OF INTERNATIONAL MEDICAL RESEARCH},
volume={53},
number={11},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Belancic Andrej,Mas Petar,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M},
year={2025},
title={Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union},
journal={NEUROLOGY INTERNATIONAL},
volume={17},
number={10},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Belancic Andrej,Raicevic Branislava B,Stevic Ivana,Vitezic Dinko,Jankovic Slobodan M},
year={2025},
title={Costs of Treating Onasemnogene Abeparvovec-Xioi-Induced Liver Injury},
journal={PHARMACOLOGY RESEARCH & PERSPECTIVES},
volume={13},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Bogdanovic M,Foumier M,Vitezic Dinko},
year={2018},
title={Cost-Utility Analysis of Insulin Glargine 300 U/Ml Versus Insulin Glargine 100 U/Ml and Insulin Degludec 100 U/Ml in Patients with Type 2 Diabetes Mellitus in Croatia},
journal={VALUE IN HEALTH},
volume={21},
number={},
pages={S131-S132},
document_type={Meeting Abstract},
}